[HTML][HTML] Omicron SARS-CoV-2 variant of concern: a review on its transmissibility, immune evasion, reinfection, and severity

M Mohsin, S Mahmud - Medicine, 2022 - journals.lww.com
Medicine Log in or Register Get new issue alertsGet alerts Secondary Logo Journal Logo
Advanced Search Toggle navigation Register Login Articles & Issues Browse by Specialty …

[HTML][HTML] Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges

E Amanatidou, A Gkiouliava, E Pella, M Serafidi… - Metabolism open, 2022 - Elsevier
Vaccination programs against SARS-CoV-2 constitute the mainstay of public health
interventions against the global COVID-19 pandemic. Currently available vaccines have …

Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2

O Puhach, K Adea, N Hulo, P Sattonnet, C Genecand… - Nature medicine, 2022 - nature.com
Infectious viral load (VL) expelled as droplets and aerosols by infected individuals partly
determines transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Rebound of SARS-CoV-2 infection after nirmatrelvir–ritonavir treatment

ME Charness, K Gupta, G Stack… - … England Journal of …, 2022 - Mass Medical Soc
Rebound of SARS-CoV-2 Infection after Nirmatrelvir–Ritonavir Treatment | New England Journal
of Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

[HTML][HTML] Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study

S Hakki, J Zhou, J Jonnerby… - The Lancet …, 2022 - thelancet.com
Background Knowledge of the window of SARS-CoV-2 infectiousness is crucial in
develo** policies to curb transmission. Mathematical modelling based on scarce empirical …

Efficacy and safety of ensitrelvir in patients with mild-to-moderate coronavirus disease 2019: the phase 2b part of a randomized, placebo-controlled, phase 2/3 study

H Mukae, H Yotsuyanagi, N Ohmagari… - Clinical Infectious …, 2023 - academic.oup.com
Background This phase 2b part of a randomized phase 2/3 study assessed the efficacy and
safety of ensitrelvir for mild-to-moderate coronavirus disease 2019 (COVID-19) during the …

Impaired detection of omicron by SARS-CoV-2 rapid antigen tests

A Osterman, I Badell, E Basara, M Stern… - Medical microbiology …, 2022 - Springer
Since autumn 2020, rapid antigen tests (RATs) have been implemented in several countries
as an important pillar of the national testing strategy to rapidly screen for infections on site …

Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study

Z Chen, X Deng, L Fang, K Sun, Y Wu… - The Lancet Regional …, 2022 - thelancet.com
Summary Background In early March 2022, a major outbreak of the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) Omicron variant spread rapidly throughout …

[HTML][HTML] Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons

C Chaguza, A Coppi, R Earnest, D Ferguson… - Med, 2022 - cell.com
Summary Background The SARS-CoV-2 Omicron variant became a global concern due to
its rapid spread and displacement of the dominant Delta variant. We hypothesized that part …

Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An updated systematic review and meta-analysis with meta-regression analyzing …

LE Brümmer, S Katzenschlager, S McGrath… - PLoS …, 2022 - journals.plos.org
Background Comprehensive information about the accuracy of antigen rapid diagnostic
tests (Ag-RDTs) for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is …